Ac-Pro-Gly-Pro-OH

CAS No. 292171-04-1

Ac-Pro-Gly-Pro-OH( —— )

Catalog No. M36655 CAS No. 292171-04-1

Ac-Pro-Gly-Pro-OH is an acetyl-modified tripeptide compound that acts as a CXCR2 agonist, exhibiting bactericidal and anti-inflammatory activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 58 Get Quote
5MG 82 Get Quote
10MG 119 Get Quote
25MG 182 Get Quote
50MG 273 Get Quote
100MG 412 Get Quote
500MG 954 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ac-Pro-Gly-Pro-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac-Pro-Gly-Pro-OH is an acetyl-modified tripeptide compound that acts as a CXCR2 agonist, exhibiting bactericidal and anti-inflammatory activities.
  • Description
    Ac-Pro-Gly-Pro-OH is an endogenous degradation product of extracellular collagen and can be used as CXCR2 agonist. Ac-Pro-Gly-Pro-OH elicits bactericidal activity and inhibits lung inflammation, reducing immune cell apoptosis. Ac-Pro-Gly-Pro-OH enhances the production of type 1 cytokines (IFN-γ and IL-12) but inhibits the production of proinflammatory cytokines. Ac-Pro-Gly-Pro-OH has the potential for the research of sepsis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | CXCR | Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    292171-04-1
  • Formula Weight
    311.33
  • Molecular Formula
    C14H21N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NCC(=O)N1[C@H](C(O)=O)CCC1)(=O)[C@H]2N(C(C)=O)CCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Patel DF, et al The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease. Eur Respir Rev. 2018 Jun 27;27(148):180017.?
molnova catalog
related products
  • TJ08

    TJ08 is a 1,2,5-trisubstituted benzimidazole derivative with anticancer properties that effectively induces G1/S phase blockade while promoting apoptotic effects in a variety of cancer cells.

  • BC 11 hydrobromide

    BC 11 hydrobromide is a selective TMPRSS2 and urokinase (uPA) inhibitor.BC-11 induces diminished mitochondrial activity, promotes reactive oxygen species production, and promotes apoptosis, and can be used in the study of breast cancer.

  • SCFSkp2-IN-2

    SCFSkp2-IN-2, a Skp2 inhibitor, exhibits a dissociation constant (K_D) of 28.77 μM. It demonstrates antitumor activities by inducing apoptosis in non-small cell lung cancer (NSCLC) cells.